Clinical Trials on Aneuploidy in Canada

Total 18 results

Clinique Ovo

Active, not recruiting

DFI and Aneuploidies

Embryo Disorder

Canada
Olive Fertility Centre
Thermo Fisher Scientific, Inc; Sequence46

Recruiting

Noninvasive Chromosomal Screening for Embryo Selection Trial (NICEST)

Infertility | Aneuploidy

Canada
University of Toronto
Ferring Pharmaceuticals

Terminated

The Effect of Co Enzyme Q10 Together With Fertility Drugs on Pregnancy Outcome of in Vitro Fertilization (CoQ10-IVF)

Pregnancy | Miscarriage | Aneuploidy

Canada
CHU de Quebec-Universite Laval
University of British Columbia; McGill University; Canadian Institutes of Health... and other collaborators

Active, not recruiting

PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood (PEGASUS-2)

Aneuploidy | Prenatal Disorder

Canada
BioCeryx
University of British Columbia; University College London Hospitals; Brugmann... and other collaborators

Unknown

Automated Screen for Fetal Aneuploidy (FAST1)

Trisomy 21 and Other Fetal Aneuploidy

Australia, United Kingdom, Spain, Canada, Belgium, Portugal
Sequenom, Inc.

Recruiting

Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy

Down Syndrome | Fetal Aneuploidy

United States, Canada
Sequenom, Inc.

Completed

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Down Syndrome | Fetal Aneuploidy

United States, Canada
Illumina, Inc.
Reprogenetics; Genesis Genetics

Completed

Single Embryo TrAnsfeR of Euploid Embryo (STAR)

Infertility | Aneuploidy

United States, Canada, Australia, United Kingdom
CHU de Quebec-Universite Laval

Recruiting

Scaling a Decision Aid on Prenatal Screening for Trisomy 21, 18 and 13 (PEGASUS-II)

Decision Aid

Canada
Clinique Ovo

Active, not recruiting

Paternal Age and Fetal Aneuploidy

Trisomy 21

Canada
Clinique Ovo

Terminated

Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21 (PlGF)

Pregnancy

Canada
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

Leukemia

United States, Canada
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); Laval University; Genome British... and other collaborators

Completed

Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood (PEGASUS)

Trisomy 21 | Trisomy 18 | Trisomy 13

Canada
Roche Sequencing Solutions
Perinatal Quality Foundation: Nuchal Translucency Quality Review

Completed

Non-invasive Chromosomal Examination of Trisomy Study (NEXT)

Trisomy 21

United States, Belgium, Netherlands, Sweden, Italy, Canada
Women and Infants Hospital of Rhode Island
Sequenom, Inc.

Completed

A New Prenatal Blood Test for Down Syndrome (RNA)

Down Syndrome | Trisomy 21

United States, Canada, Israel, Hungary, Ireland, Argentina, Australia, Czech Republic, Italy, Spain
Women and Infants Hospital of Rhode Island
PerkinElmer, Inc.

Completed

VAlidation of a Lower Cost aneUploidy scrEen (VALUE)

Down Syndrome | Trisomy 18 | Trisomy 13

United States, Canada, Italy
Natera, Inc.

Completed

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies (VANISH)

Trisomy 21 | Trisomy 18 | Trisomy 13 | Vanishing Twin

United States
Natera, Inc.
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Terminated

Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)

Aneuploidy | Trisomy 21 | Trisomy 18 | Trisomy 13

United States, Ireland, Canada, Italy, Korea, Republic of, Spain

Clinical Trials on Aneuploidy in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations